Home  >> Transactions>> Harvard Bioscience acquires AHN Biotechnologie

Harvard Bioscience acquires AHN Biotechnologie

Harvard Bioscience, Inc. (Nasdaq: HBIO), Holliston, MA, a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has acquired AHN Biotechnologie GmbH (“AHN”). Based in Nordhausen, Germany, AHN is a manufacturer of plastic consumable laboratory products including pipette tips.  This acquisition is complementary to Harvard’s Biochrom product line of molecular biology instruments. EC Mergers & Acquisitions acted as exclusive financial advisor to Harvard Bioscience on this transaction.


Dickson Data has been sold to May River Capital      Learn More >>
SPX has acquired Schonstedt Instrument Company      Learn More >>
Quantachrome Instruments has been sold to Anton Paar      Learn More >>
PIP Global has partnered with Audax Private Equity      Learn More >>
Harvard Bioscience has acquired Data Sciences International      Learn More >>
Horizon Technology has been sold to Biotage      Learn More >>
Norsk Elektro Optikk has sold NEO Monitors to Nederman      Learn More >>
AppliTek has been acquired by Hach / Danaher      Learn More >>
4titude is sold to Brooks Automation      Learn More >>
FFL Partners has acquired Bacharach      Learn More >>
Aliaxis has sold SED to Samson      Learn More >>
Spectris has sold Microscan to Omron      Learn More >>